. Author manuscript; available in PMC: 2017 Jul 18.

Published in final edited form as: Sci Transl Med. 2017 Jan 18;9(373):eaag2196. doi: 10.1126/scitranslmed.aag2196

Table 1.

Imaging and demographic data for all seven patients enrolled in this study.

Patient #	1	2	3	4	5	6	7
Gender	M	F	F	M	F	M	M
Age (years)	57	41	61	62	53	66	60
CTL type	autologous	autologous	allogeneic	allogeneic	allogeneic	allogeneic	allogeneic
Histology	Glioma	Glioma	Glioma	Glioma	Glioma	Glioma	Glioma
IL13Rα2 expression	N/A	N/A	2-3+ / 80%	2-3+ / 80%	2-3+ / 70%	2+ / 60%	2+ / 90%
Site of primary tumor	right parietal	right parieto-occipital	splenium of corpus callosum and left parietal	right occipital	left temporal	right fronto-parietal	left frontal
Site of recurrence	right occipital	right parieto-occipital	splenium of corpus callosum and left parietal	genu of corpus collosum and bifrontal	left temporal	right fronto-parietal	left parietal
MRI pre-CTL	08/03/2006	15/01/2009	23/03/2011	15/02/2012	09/05/2012	12/09/2012	06/03/2013
MRI post-CTL	18/04/2006	25/02/2009	15/05/2011	12/03/2012	05/06/2012	08/10/2012	26/03/2013
[¹⁸F]FDG pre-CTL	09/03/2006	14/01/2009	23/03/2011	15/02/2012	10/05/2012	14/09/2012	08/03/2013
[¹⁸F]FDG post-CTL	N/A	N/A	16/05/2011	17/03/2012	06/06/2012	08/10/2012	27/03/2013
[¹⁸F]FHBG pre-CTL	N/A	05/01/2009	21/04/2011	17/02/2012	11/05/2012	13/09/2012	07/03/2013
[¹⁸F]FHBG post-CTL	17/04/2006	23/02/2009	09/05/2011	06/03/2012	01/06/2012	04/10/2012	28/03/2013

Lesion total activity pre-CTL	-	10.1	3.5	2.9	23.1	4.1	1.8
Lesion total activity post-CTL	#1, 4.9; #2, 0.8	20.3	8.4	6.3	28.1	8.4	6.8
Non-injected foci total activity pre-CTL	-	-	-	2.4	-	-	1.6
Non-injected foci total activity post-CTL	-	-	-	3.2	-	-	2.7